SCHEMBL25124377

SCHEMBL25124377

CC(C)Nc1ccc2c(c1)CCOC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 1/20 0.38
HTR6 P50406 1/20 0.36
TDP1 Q9NUW8 2/20 0.34
MAP4K1 Q92918 1/20 0.34
ALDH1A1 P00352 3/20 0.34
ALOX15 P16050 2/20 0.34
HSD17B10 Q99714 2/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
RECQL P46063 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RAPGEF4 Q8WZA2 1/20 0.34
MAPK1 P28482 1/20 0.33
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
POLB P06746 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094147 0.86 TDP1 (0.39) HTR6TDP1ALDH1A1ALOX15HSD17B10
SCHEMBL24783883 0.81 MAP4K1 (0.36) P2RX3HTR6MAP4K1ALDH1A1ALOX15
SCHEMBL14017824 0.78 RAPGEF4 (0.51) HTR6ALDH1A1LMNATHRBL3MBTL1
SCHEMBL24783494 0.78 RAPGEF4 (0.47) HTR6ALDH1A1LMNATHRBL3MBTL1
SCHEMBL11816447 0.75 PKLR (0.45) RAB9AMAPTPKMNPSR1
SCHEMBL11816251 0.75 CYP1A2 (0.39) TDP1TSHRMAPTNPSR1
SCHEMBL21894537 0.74 BTK (0.38) P2RX3MAP4K1ALDH1A1ALOX15RAPGEF4
SCHEMBL3430968 0.74 KCNH2 (0.35) P2RX3ALDH1A1ALOX15HSD17B10LMNA
SCHEMBL28939591 0.73 ALDH1A1 (0.34) P2RX3HTR6MAP4K1ALDH1A1ALOX15
SCHEMBL13146614 0.73 P2RX3 (0.36) P2RX3ALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230109839-A1 THERAPEUTIC AGENT FOR TAUOPATHIES Sumitomo Pharma Co., Ltd. (JP) 2023-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230109839-A1 THERAPEUTIC AGENT FOR TAUOPATHIES MAPT, PSEN1, PSEN2 P2RX3 597/4885HTR6 1743/4885TDP1 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.